MICROBIOTIX

MicrobiotiX strives to develop treatments
 for global intractable diseases
such as multidrug-resistant
bacterial infections, autoimmune diseases and cancer

MICROBIOME

Phage, Microbiome
& Beyond

MICROBIOTA BANK (NON-PROFIT)

By providing FMT fecal microbiota for CDI-targeted diseases to 26 university hospitals nationwide, it showed therapeutic effects in more than 90% of patients with severe chronic C. difficile infection. We have established microbiota banking through risk factor screening based on international guidelines. We supply FMT to hospitals across the nation for clinical use. It is a liquid or oral capsule that can be selected according to the patient’s condition and preference.


01

FECAL MICROBIOTA
BANK

In 2017, we established the fecal banking necessary for the development of microbiome-based treatments. Through a microbiota bank with independent and strict risk factor screening we have supplied microbiota to hospitals nationwide.


02

FECAL MICROBIOTA
CLINICAL SERVOCE

FMT fecal microbiota was provided to patients in 26 university hospitals across the nation. For patients with C. difficile, excellent treatment results and improvement was recorded. We have received numerous donations. About 1,000 people were screened and around 400 procedures were performed.


03

FECAL MICROBIOTA
TYPE

A liquid or oral capsule can be selected according to the patient’s condition and preference. It can maximize the synergetic effect of microbiome treatments when used in conjunction with bacteriophages.

CUSTOS
PLATFORM

01  Collect and analyze 1,000 types of pathogens in a month (cell banking)

02  Analyze the interaction between the bacteria and the bacteriophage

03  Analyze the modulation of the microbiome (phageome)

04  Bacteriophage Preparation (CMC Optimization) 

05  cGMP level Production Establishment

06  Use the custos platform for quick, diverse pipeline expansion

FMT DONER
RECRUITMENT AND INQUIRY


E-Mail : zoatk7103@microbiotix.net
Selection criteria

Men and women aged 20-49 (non-smokers)

Residents of Seoul or the Seoul Metropolitan area that can visit Severance Hospital 

Excluded : In the case when one does not pass the given questionnaire

How to participate

Click the link below, fill out the questionnaire, and wait for further contact

Participation benefits

When participating in this study, blood, breath, and fecal tests are performed free of charge. 

Depending on the result, if it is acceptable, we are willing to provide a small honorarium

MICROBIOTIX CO., LTD

Severance Hospital Clinical Research Center #221   l   TEL : 02. 6379. 2649   l   E-mail : mx@microbiotix.net

Copyright © MICROBIOTIX. All rights reserved.

Privacy Policy     Prohibition of Unauthorized Email Collection